AU2001283055A1 - Biological component comprising artificial membrane - Google Patents

Biological component comprising artificial membrane

Info

Publication number
AU2001283055A1
AU2001283055A1 AU2001283055A AU8305501A AU2001283055A1 AU 2001283055 A1 AU2001283055 A1 AU 2001283055A1 AU 2001283055 A AU2001283055 A AU 2001283055A AU 8305501 A AU8305501 A AU 8305501A AU 2001283055 A1 AU2001283055 A1 AU 2001283055A1
Authority
AU
Australia
Prior art keywords
biological component
artificial membrane
artificial
membrane
biological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001283055A
Inventor
Elliot L Chaikof
Keith M. Faucher
June Feng
Hongbo Liu
Janine M. Orban
Xue Long Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emory University
Original Assignee
Emory University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emory University filed Critical Emory University
Publication of AU2001283055A1 publication Critical patent/AU2001283055A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/222—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0076—Chemical modification of the substrate
    • A61L33/0082—Chemical modification of the substrate by reacting with an organic compound other than heparin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1273—Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10—Esters
    • C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
    • C08F220/28—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety
    • C08F220/281—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety and containing only one oxygen, e.g. furfuryl (meth)acrylate or 2-methoxyethyl (meth)acrylate
AU2001283055A 2000-07-28 2001-07-30 Biological component comprising artificial membrane Abandoned AU2001283055A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US22165500P 2000-07-28 2000-07-28
US22182800P 2000-07-28 2000-07-28
US22161800P 2000-07-28 2000-07-28
US60/221,618 2000-07-28
US60/221,828 2000-07-28
US60/221,655 2000-07-28
PCT/US2001/024020 WO2002009647A2 (en) 2000-07-28 2001-07-30 Biological component comprising artificial membrane

Publications (1)

Publication Number Publication Date
AU2001283055A1 true AU2001283055A1 (en) 2002-02-13

Family

ID=27396969

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001283055A Abandoned AU2001283055A1 (en) 2000-07-28 2001-07-30 Biological component comprising artificial membrane

Country Status (5)

Country Link
US (1) US7713544B2 (en)
EP (1) EP1317253A4 (en)
JP (1) JP2004512062A (en)
AU (1) AU2001283055A1 (en)
WO (1) WO2002009647A2 (en)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
AU2001253456A1 (en) * 2000-04-13 2001-10-30 Emory University Antithrombogenic membrane mimetic compositions and methods
US7713544B2 (en) 2000-07-28 2010-05-11 Emory University Biological component comprising artificial membrane
US7244830B2 (en) 2001-01-12 2007-07-17 Emory University Glycopolymers and free radical polymerization methods
DE10121903A1 (en) * 2001-04-27 2002-10-31 Nimbus Biotechnologie Gmbh System for membrane permeation measurement
AU2003241531A1 (en) * 2002-05-21 2003-12-12 Emory University Multivalent polymers with chain-terminating binding groups
FR2855521B1 (en) * 2003-05-28 2005-08-05 Flamel Tech Sa POLYAMINOACIDES FUNCTIONALIZED BY AT LEAST ONE YDROPHOBIC GROUP AND THEIR PARTICULARLY THERAPEUTIC APPLICATIONS.
WO2005042043A2 (en) 2003-10-28 2005-05-12 Medtronic, Inc. Methods of preparing crosslinked materials and bioprosthetic devices
CA2545653C (en) * 2003-11-21 2014-07-08 Anp Technologies, Inc. Asymmetrically branched polymer conjugates and microarray assays
US8002830B2 (en) 2004-02-06 2011-08-23 Georgia Tech Research Corporation Surface directed cellular attachment
AU2005212339B2 (en) * 2004-02-06 2010-11-25 Georgia Tech Research Corporation Load bearing biocompatible device
US20080108515A1 (en) * 2004-02-10 2008-05-08 Gormley Niall A Arrayed polynucleotides
US7833978B2 (en) 2004-02-20 2010-11-16 Emory University Thrombomodulin derivatives and conjugates
US7354980B1 (en) 2004-03-12 2008-04-08 Key Medical Technologies, Inc. High refractive index polymers for ophthalmic applications
US7824672B2 (en) 2004-03-26 2010-11-02 Emory University Method for coating living cells
US8696564B2 (en) 2004-07-09 2014-04-15 Cardiac Pacemakers, Inc. Implantable sensor with biocompatible coating for controlling or inhibiting tissue growth
AU2005277203A1 (en) * 2004-08-20 2006-03-02 Entremed, Inc. Compositions and methods comprising proteinase activated receptor antagonists
US7446157B2 (en) 2004-12-07 2008-11-04 Key Medical Technologies, Inc. Nanohybrid polymers for ophthalmic applications
PL2179780T3 (en) * 2005-05-20 2013-03-29 Aquaporin As Membrane for filtering of water
JP5021183B2 (en) 2005-05-20 2012-09-05 アークレイ株式会社 Protein immobilization membrane, immobilization method, and biosensor
JP5214857B2 (en) * 2005-06-20 2013-06-19 東レ株式会社 Porous substrate
US8053559B2 (en) * 2005-10-27 2011-11-08 Coloplast A/S Biodegradable scaffold with ECM material
PT2013332E (en) * 2006-04-17 2012-02-20 Philadelphia Medical Scient Ct L L C Cell therapy: a method and a composition for treating diabetes
US20090269313A1 (en) * 2006-07-19 2009-10-29 Diakine Therapeutics, Inc. Encapsulation system
WO2008021391A1 (en) 2006-08-15 2008-02-21 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
WO2008033847A2 (en) 2006-09-11 2008-03-20 Emory University Modified protein polymers
US8071135B2 (en) 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
CN104623643A (en) 2006-10-06 2015-05-20 人类起源公司 Natural (telopeptide) placental collagen compositions
US20080181928A1 (en) * 2006-12-22 2008-07-31 Miv Therapeutics, Inc. Coatings for implantable medical devices for liposome delivery
US8622991B2 (en) 2007-03-19 2014-01-07 Insuline Medical Ltd. Method and device for drug delivery
US9220837B2 (en) 2007-03-19 2015-12-29 Insuline Medical Ltd. Method and device for drug delivery
KR20090128499A (en) 2007-03-19 2009-12-15 인슐린 메디컬 엘티디 Drug delivery device
GB0709259D0 (en) * 2007-05-14 2007-06-20 Ucl Business Plc Pores
WO2009003936A2 (en) * 2007-06-29 2009-01-08 Universite Joseph Fourier - Grenoble 1 Biomimetic artificial membrane device
CA2702183A1 (en) * 2007-10-10 2009-04-16 Miv Therapeutics Inc. Lipid coatings for implantable medical devices
EP2231229A1 (en) 2007-12-18 2010-09-29 Insuline Medical Ltd. Drug delivery device with sensor for closed-loop operation
US8795707B2 (en) * 2008-05-13 2014-08-05 Trustees Of Boston University Compliant composites for application of drug-eluting coatings to tissue surfaces
US8603531B2 (en) 2008-06-02 2013-12-10 Cedars-Sinai Medical Center Nanometer-sized prodrugs of NSAIDs
EP3029467B1 (en) 2008-09-22 2020-01-08 University of Washington Msp nanopores and related methods
BRPI0916125A2 (en) 2008-11-07 2015-11-03 Insuline Medical Ltd "treatment device"
GB0901857D0 (en) * 2009-02-05 2009-03-11 Nanoco Technologies Ltd Encapsulated nanoparticles
CA2716502C (en) * 2009-05-15 2015-06-16 Interface Biologics, Inc. Antithrombogenic hollow fiber membranes and filters
US20100316787A1 (en) * 2009-06-12 2010-12-16 Greatbatch Ltd. Biomimetic Coating Method
JP5813661B2 (en) * 2009-12-31 2015-11-17 ザ チャールズ スターク ドレイパー ラボラトリー インク Microfluidic device for facilitating gas exchange and method for using and manufacturing the same
CA2790672C (en) 2010-02-23 2018-05-29 University Of Washington Artificial mycolic acid membranes
JP5688791B2 (en) * 2010-05-11 2015-03-25 グレイトバッチ リミテッドＧｒｅａｔｂａｔｃｈ Ｌｔｄ． Surface modification for coating
AU2011258203A1 (en) 2010-05-26 2013-01-10 The Charles Stark Draper Laboratory, Inc. Microfabricated artificial lung assist device, and methods of use and manufacture thereof
AU2012207206B2 (en) 2011-01-19 2015-10-08 President And Fellows Of Harvard College Slippery liquid-infused porous surfaces and biological applications thereof
US9353646B2 (en) 2011-01-19 2016-05-31 President And Fellows Of Harvard College Slippery surfaces with high pressure stability, optical transparency, and self-healing characteristics
US9155543B2 (en) 2011-05-26 2015-10-13 Cartiva, Inc. Tapered joint implant and related tools
JP5807484B2 (en) * 2011-09-27 2015-11-10 日立化成株式会社 Thin film and manufacturing method thereof
AU2012347922B2 (en) 2011-12-05 2017-12-21 The Charles Stark Draper Laboratory, Inc. Method for reducing the blood priming volume and membrane surface area in microfluidic lung assist devices
CA2878683C (en) * 2012-07-12 2021-07-20 President And Fellows Of Harvard College Slippery self-lubricating polymer surfaces
WO2014012039A1 (en) 2012-07-13 2014-01-16 President And Fellows Of Harvard College Slippery liquid-infused porous surfaces having improved stability
WO2014012052A1 (en) 2012-07-13 2014-01-16 President And Fellows Of Harvard College Slips surface based on metal-containing compound
EP2941249A4 (en) * 2013-01-07 2016-09-28 Univ Maryland Biocompatible coating compositions
GB201300465D0 (en) 2013-01-11 2013-02-27 Aquaporin As A hollow fiber module having tfc-aquaporin modified membranes
DK177696B1 (en) 2013-02-25 2014-03-17 Aquaporin As Systems for water extraction
WO2014209441A2 (en) 2013-03-13 2014-12-31 President And Fellows Of Harvard College Solidifiable composition for preparation of liquid-infused slippery surfaces and methods of applying
WO2014172663A1 (en) * 2013-04-19 2014-10-23 Cedars-Sinai Medical Center Nanometer-sized prodrugs of nsaids to treat traumatic brain injury
CN103405809B (en) * 2013-07-23 2015-01-21 东华大学 Method used for preparing microcarrier/polymer composite scaffold by electro-deposition
WO2015077401A1 (en) 2013-11-20 2015-05-28 Drexel University Compositions and methods for macrophage conversion
US11000285B2 (en) * 2013-12-17 2021-05-11 3Dt Holdings, Llc Luminal grafts and methods of making and using the same
CA3207570A1 (en) 2014-04-16 2015-10-22 The Uab Research Foundation Msp nanopores and uses thereof
WO2015164618A1 (en) 2014-04-23 2015-10-29 The Charles Stark Draper Laboratory, Inc. Blood oxygenator
WO2016004029A1 (en) * 2014-06-30 2016-01-07 The Arizona Board Of Regents On Behalf Of The University Of Arizona Systems and methods of preparing stabilized lipid assemblies
US9782727B2 (en) 2014-07-14 2017-10-10 International Business Machines Corporation Filtration membranes with functionalized star polymers
CN104177638B (en) * 2014-08-23 2016-10-12 吉林大学 Ordered porous polymer thin film, preparation method and the application in terms of capture and controlled sugar response uelralante
US9931598B2 (en) 2015-02-16 2018-04-03 International Business Machines Corporation Anti-fouling coatings with star polymers for filtration membranes
US10005042B2 (en) 2015-02-16 2018-06-26 International Business Machines Corporation Thin film composite forward osmosis membranes with performance enhancing layers
US10758374B2 (en) 2015-03-31 2020-09-01 Cartiva, Inc. Carpometacarpal (CMC) implants and methods
AU2016243659B2 (en) 2015-03-31 2020-04-23 Cartiva, Inc. Hydrogel implants with porous materials and methods
CA2981074C (en) 2015-04-14 2023-03-28 Cartiva, Inc. Tooling for creating tapered opening in tissue and related methods
DE102016107480B4 (en) * 2016-04-22 2018-01-04 Christian-Albrechts-Universität Zu Kiel Layer with variable strength
CN109735434B (en) * 2016-09-14 2022-09-23 四川蓝光英诺生物科技股份有限公司 Artificial tissue precursors and methods of making the same
EP3529300A4 (en) 2016-10-18 2020-03-18 Evonik Canada Inc. Plasticized pvc admixtures with surface modifying macromolecules and articles made therefrom
EP3652229A1 (en) 2017-07-14 2020-05-20 Fresenius Medical Care Holdings, Inc. Method for providing surface modifying composition with improved byproduct removal
DE102018126842B4 (en) * 2018-10-26 2020-10-15 Carl Zeiss Meditec Ag Ophthalmic implant, method for producing an ophthalmic implant and use of a ligand for producing an ophthalmic implant
CN109925540B (en) * 2019-03-14 2021-04-16 西南交通大学 Method for mediating albumin to form protein layer on surface of material, biological material and application of biological material
CN110305253A (en) * 2019-06-30 2019-10-08 海南师范大学 Aoxidize homogeneous bracket of alginate/polyacrylamide interpenetrating networks medical composite type and preparation method thereof
US20210093435A1 (en) 2019-09-27 2021-04-01 Isla Technologies, Inc. Bioartificial pancreas
CN110693836A (en) * 2019-10-21 2020-01-17 中国石油大学(华东) Lipopeptide self-assembly ultra-small nano vesicle and preparation method thereof
CN111203115B (en) * 2020-01-07 2022-02-11 天津市第三中心医院 Oxidized polysaccharide anticoagulant coating hemodialysis membrane material and preparation method thereof
CN111437442B (en) * 2020-05-08 2021-09-21 江南大学 Preparation method of degradable electrophoretic coating for magnesium-based medical implant surface
KR20230169174A (en) * 2021-04-09 2023-12-15 윌리엄 마쉬 라이스 유니버시티 Interfacial seeding of cells and particles on surfaces for diagnosis and therapy
CN115282341B (en) * 2022-06-27 2023-05-23 华南理工大学 Porous metal material with polypeptide bidirectional gradient distribution surface and preparation method and application thereof
CN115814159B (en) * 2023-02-23 2023-05-05 四川兴泰普乐医疗科技有限公司 Artificial crystal and preparation method thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4522803A (en) 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
US4560599A (en) 1984-02-13 1985-12-24 Marquette University Assembling multilayers of polymerizable surfactant on a surface of a solid material
MX9203291A (en) 1985-06-26 1992-08-01 Liposome Co Inc LIPOSOMAS COUPLING METHOD.
US4885172A (en) * 1985-06-26 1989-12-05 The Liposome Company, Inc. Composition for targeting, storing and loading of liposomes
US5755788A (en) 1987-02-19 1998-05-26 Rutgers, The State University Prosthesis and implants having liposomes bound thereto and methods of preparation
US4880883A (en) 1987-06-03 1989-11-14 Wisconsin Alumni Research Foundation Biocompatible polyurethanes modified with lower alkyl sulfonate and lower alkyl carboxylate
US4906465A (en) 1987-10-19 1990-03-06 Massachusetts Institute Of Technology Antithrombogenic devices containing polysiloxanes
US5288517A (en) 1988-08-26 1994-02-22 Canon Kabushiki Kaisha Method of forming planar membrane
FR2640955B1 (en) 1988-12-26 1991-11-29 Taillet Joseph
SE466259B (en) * 1990-05-31 1992-01-20 Arne Forsgren PROTEIN D - AN IGD BINDING PROTEIN FROM HAEMOPHILUS INFLUENZAE, AND THE USE OF THIS FOR ANALYSIS, VACCINES AND PURPOSE
EP0489180A4 (en) * 1990-06-27 1993-03-31 Mochida Pharmaceutical Co., Ltd. Anticoagulant polypeptides
WO1993005825A1 (en) 1991-09-20 1993-04-01 Baxter International Inc. Processes for reducing the thrombogenicity of biomaterials
EP0597593A1 (en) 1992-10-30 1994-05-18 Medtronic, Inc. Thromboresistant articles
AU8012394A (en) 1993-10-01 1995-05-01 Emory University Self-expanding intraluminal composite prosthesis
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
AU717673B2 (en) * 1995-09-19 2000-03-30 Seikagaku Corporation Anti-inflammatory agent
US5911942A (en) 1995-11-02 1999-06-15 Tissue Engineering, Inc. Method for spinning and processing collagen fiber
US6071532A (en) 1996-10-15 2000-06-06 Emory University Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof
GB9704749D0 (en) * 1997-03-07 1997-04-23 Univ London Tissue Implant
US6071614A (en) * 1997-07-14 2000-06-06 3M Innovative Properties Company Microporous fluorinated silica agglomerate and method of preparing and using same
US6583251B1 (en) * 1997-09-08 2003-06-24 Emory University Modular cytomimetic biomaterials, transport studies, preparation and utilization thereof
US6214049B1 (en) * 1999-01-14 2001-04-10 Comfort Biomedical, Inc. Method and apparatus for augmentating osteointegration of prosthetic implant devices
EP1032436A1 (en) 1998-06-30 2000-09-06 Emory University Modular cytomimetic biomaterials, transport studies, preparation and utilization thereof
AU2001253456A1 (en) * 2000-04-13 2001-10-30 Emory University Antithrombogenic membrane mimetic compositions and methods
WO2001080921A2 (en) 2000-04-20 2001-11-01 Emory University Native protein mimetic fibers, fiber networks and fabrics for medical use
US7713544B2 (en) 2000-07-28 2010-05-11 Emory University Biological component comprising artificial membrane
US7244830B2 (en) 2001-01-12 2007-07-17 Emory University Glycopolymers and free radical polymerization methods

Also Published As

Publication number Publication date
EP1317253A2 (en) 2003-06-11
US20040063200A1 (en) 2004-04-01
JP2004512062A (en) 2004-04-22
WO2002009647A3 (en) 2002-07-25
US7713544B2 (en) 2010-05-11
EP1317253A4 (en) 2006-04-26
WO2002009647A2 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
AU2001283055A1 (en) Biological component comprising artificial membrane
AU2001273164A1 (en) Membrane associated protein zupari
AU2001286207A1 (en) Porous membrane
AU2001233227A1 (en) Artificial heart valve
AU9517301A (en) Implant
AU2001231447A1 (en) Artificial tree
AU6906800A (en) Membrane associated proteins
AU7862200A (en) Flip-wing tissue retainer
AU2001238359A1 (en) Membranes
AU2001276692A1 (en) Modified hollow-fiber membrane
AU2023301A (en) Improved prosthesis
AU2001263841A1 (en) Implant
AU2001256020A1 (en) Biological sounds monitor
AU2001259702A1 (en) Tissue regrafting
AU2002360067A1 (en) Permeable membrane
AU2002358214A1 (en) Membrane
AU2203901A (en) Microporous membrane
AU2002227925A1 (en) Human beta-defensin-3
AU4081900A (en) Porous membrane
AU2001242738A1 (en) Novel artificial organ system
AUPR069500A0 (en) Tissue modification
AU2001228324A1 (en) Biological microsensor
AU2002211097A1 (en) Artificial manes
AU2002246344A1 (en) Artificial dialysis
AU1198701A (en) Novel human membrane proteins